Bionano to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference
04 sept. 2024 08h00 HE
|
Bionano Genomics
Bionano to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress
07 août 2024 16h01 HE
|
Bionano Genomics
Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress
Bionano Announces Presentation of Optical Genome Mapping Utility Across Cancer Research Applications at the Cancer Genomics Consortium (CGC) 2024 Annual Meeting
01 août 2024 08h00 HE
|
Bionano Genomics
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- A sponsored exhibitor session will feature Dr. Phillip Michaels from Harvard Medical School and Brigham and Women’s Hospital presenting data from a...
Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference
31 juil. 2024 16h01 HE
|
Bionano Genomics
SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the...
Bionano to Report Second Quarter 2024 Financial Results and Host a Conference Call and Webcast on August 7, 2024
31 juil. 2024 08h00 HE
|
Bionano Genomics
SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, August 7, 2024, at 4:30 p.m....
Bionano Announces Publication of First Multi-Site Study to Analyze the Utility of OGM in Multiple Myeloma
23 juil. 2024 08h00 HE
|
Bionano Genomics
SAN DIEGO, July 23, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the publication of the first multi-site study in multiple myeloma (MM) comparing optical genome...
Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
08 juil. 2024 17h25 HE
|
Bionano Genomics
SAN DIEGO, July 08, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the closing of its previously announced registered direct offering priced at-the-market under...
Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
05 juil. 2024 08h00 HE
|
Bionano Genomics
SAN DIEGO, July 05, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has entered into definitive agreements with healthcare-focused institutional investors for...
Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual Meeting
02 juil. 2024 08h00 HE
|
Bionano Genomics
A sponsored session will feature Dr. Lucia Gallego Villarejo from Ruhr University Bochum, Dr. Jeanne Loring from Scripps Research Institute, and Dr. Alicia Bertolotti from Bionano presenting on the...
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research
20 juin 2024 08h00 HE
|
Bionano Genomics
Bionano announces software marketing agreement with Revvity for newborn sequencing research workflow.